It has. I think Canada has to recognize that it's in a globally competitive industry, so it has to adopt policies that are actually going to allow the industry to compete globally and to also participate here.
It's part of why we have seen a little bit of the industry disappear in Canada. We have adopted pricing policies that make it somewhat inhospitable for a lot of those companies to be here. If we think about going forward, we have to figure out how to get through the immediate period ahead with some of the challenges that are coming with the variants and mutations.
Looking ahead, I think the large multinationals are going to be an absolutely critical part of partnering with companies like VIDO-InterVac, Medicago and other Canadian entities that are here in this country. That partnership is going to be absolutely critical going forward.